I recently had the privilege of sitting through four investigator meetings, two in the United States and two in Europe. They comprised speaker after speaker with slide after slide. Topics included the disease, the drug, the PK, the efficacy and
You may be aware that I’ve been going to investigator meetings and finding them kind of out-of-date. We’ve got to get away from what’s easy for the sponsor, and instead move toward what is effective for the investigators and their
A very thoughtful client, and subscriber to our Presentation Pointers, sent me this email: I have a question – Can you offer me 1-2 tips for giving presentation feedback for senior and mid-level managers? Examples of areas where feedback is